The impact of primary diseases is substantial, demanding groundbreaking therapeutic options. Cellular therapies represent a especially hopeful avenue, offering the chance to restore damaged hepatic tissue and alleviate patient outcomes. Currently, research focuses on several approaches, including the delivery of adult regenerative units directly in